Blood-sucking little insects. What good are they? They just take and take and take.
I’m not talking about your hatred for Wall Street Banksters. Nope. Literally, I mean the little flying hypodermic needles filled with disease.
OF 108 COUNTRIES where malaria is endemic, ten are on track to eliminate the disease in the near future, according to a report by Roll Back Malaria published on October 18th. For many others getting to zero deaths from the parasite is a distant dream. But that should not stop a celebration of the progress that has been made over the past decade, during which time deaths from malaria have fallen by 20% (see chart). The correlation between reduced deaths and money spent is fairly strong, much more so than the correlation between conventional aid and economic development. Given that improved health often comes before advances in GDP per capita, spending on malaria may eventually show an even greater return than it already has to date.
And there’s more good news today from USA Today, a new vaccine is in the works for Malaria. If successful, this would be the first vaccine ever for the nasty disease, and could save millions of lives– or turns us all into flesh eating zombies, either way the mosquitoes lose.
The project is a collaboration between GlaxoSmithKline, the PATH Malaria Vaccine Initiative and the Bill & Melinda Gates Foundation. It is being funded in part by more than $200 million in grants from the Bill & Melinda Gates Foundation and $300 million from GlaxoSmithKline ($GSK).
No position held in GSK at this time